Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy.

ABSTRACT:

Background

Among patients receiving opioid agonist therapy, 85% are active tobacco smokers. Despite the significant impact of smoking-related pulmonary diseases on disability and mortality in this population, less than 10% successfully quit smoking with current interventions. The study aimed to evaluate the feasibility of integrating a smoking cessation intervention at outpatient clinics for persons receiving opioid agonist treatment. The specific outcomes were the feasibility of integration, intervention acceptability, participant retention, and the trial's impact on smoking behaviour.

Methods

We conducted a 12-week feasibility study among patients receiving OAT (n = 25) in 2021 in Bergen, Norway. The feasibility outcomes were evaluated using qualitative semi-structured int

SUBMITTER: Druckrey-Fiskaaen KT 

PROVIDER: S-EPMC12577004 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature